Triage Plus was designed to detect mRNAs and DNA single-nucleotide variants from fibroblast growth factor receptor 3 and telomerase reverse transcriptase genes associated with bladder cancer.
Experts predict a test measuring p-tau217 in blood plasma may become a standard screening tool for Alzheimer’s disease in asymptomatic patients.
With the CDC's Advisory Committee on Immunization Practices (ACIP) recommending post-vaccination antibody testing for ...
A rapid, user-friendly, highly accurate sensitive molecular test has been developed for diagnosing hepatitis C virus (HCV).
Roche’s cobas BV/CV assay gains CE Mark, enabling accurate, rapid diagnosis of bacterial vaginosis and candida vaginitis.
On December 29, 2025, Aspira Women’s Health published a new investor presentation outlining how its AI-powered, multi-omic diagnostic platform targets a more than 10.5 million–patient addressable ...
Known as Breast Circulating Methylation Assay (BCMA), the new blood test looks for tumour DNA released into the bloodstream by cancer cells ...
The blood-based test by Astrin Biosciences shows high sensitivity and specificity across cancer stages and subtypes, ...
ALZpath, Inc., a leading developer of innovative diagnostic tools for Alzheimer's and related diseases, today announced that the Simoa® ALZpath pTau217 Assay was used in a landmark population-based ...
The Hearty Soul on MSN
Scientists just developed a blood test that can diagnose chronic fatigue
Long COVID can linger long after the acute infection ends. People report fatigue, brain fog, dizziness, and poor sleep. Many ...
Siemens Healthineers AG became the latest company to sign a licensing agreement with Alzpath Inc. to use its pTau217 antibody in the development of a blood-based diagnostic assay for Alzheimer's ...
LIS Technologies is cleared to proceed with procurement of uranium hexafluoride (UF₆) feedstock and to advance research, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback